Showing results (1531-1540 of 1,729) with videos related to
Sort By:
Pageof 173
Cancer Immunology, Immunotherapy : CII|October 2, 2024
PD-1 blockade does not improve efficacy of EpCAM-directed CAR T-cell in lung cancer brain metastasisJens Blobner, Laura Dengler, Constantin Eberle, et al.Blood|February 7, 2013
EGFL7 ligates αvβ3 integrin to enhance vessel formationIva Nikolic, Nevenka Dudvarski Stankovic, Frank Bicker, et al.BMC Public Health|November 19, 2025
COVID-19 response and the unhoused communities in Sacramento: a mixed methods study with policy implicationsAnnica Stull-Lane, Kiré Lau, Monica Keiko Lieng, et al.European Journal of Cancer (Oxford, England : 1990)|June 13, 2025
Predictive value of BRCA1/RAD51C methylation in HGSOC - An ancillary study of the PAOLA-1/ENGOT-ov25 phase 3 trialH Blons, J Abdelli, S Landman, et al.Journal of the National Cancer Institute|December 28, 2021
Clonal Hematopoiesis-Associated Gene Mutations in a Clinical Cohort of 448 Patients With Ovarian CancerKonstantin Weber-Lassalle, Corinna Ernst, Alexander Reuss, et al.Gynecologic Oncology|December 25, 2021
Efficacy of maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed, advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trialPhilipp Harter, Marie Ange Mouret-Reynier, Sandro Pignata, et al.Neuro-Oncology|June 4, 2024
Disturbance in cerebral blood microcirculation and hypoxic-ischemic microenvironment are associated with the development of brain metastasisJenny Roesler, Daniel Spitzer, Xiaoxiong Jia, et al.European Journal of Human Genetics : EJHG|September 15, 2017
Detecting splicing patterns in genes involved in hereditary breast and ovarian cancerGrégoire Davy, Antoine Rousselin, Nicolas Goardon, et al.JAMA Network Open|April 9, 2024
Olaparib Addition to Maintenance Bevacizumab Therapy in Ovarian Carcinoma With BRCA-Like Genomic AberrationsPhilip C Schouten, Sandra Schmidt, Kerstin Becker, et al.European Journal of Cancer (Oxford, England : 1990)|October 27, 2023
Lymph node staging in grade 1-2 endometrioid ovarian carcinoma apparently confined to the ovary: Is it worth?Nicolò Bizzarri, Majdi Imterat, Robert Fruscio, et al.Pageof 173